WNT2 and breast cancer: It has been reported in the literature that WNT2 is overexpressed in colorectal cancer, cervical cancer, human fibroadenomas, pancreatic cancer, and breast cancer, thereby triggering migration and invasion [60, 61, 62, 63, 64].